Review: EzGrip Pens and Grips
Saturday October 30, 2004
The EzGrip Pen by Dexterity Technologies Corp. is designed to restore writing ability and diminish problems caused by arthritis of the hand, fingers, carpal tunnel, or any hand difficulty. ... Read More
Arcoxia Approval Delayed By FDA
Friday October 29, 2004
Merck & Co., Inc. has received an "approvable" letter from the U.S. Food and Drug Administration for Arcoxia. The FDA is requiring additional safety and efficacy data for Arcoxia before ... Read More
Canadian Study: Glucosamine Shows No Long-Term Benefit
Thursday October 28, 2004
Glucosamine is a popular nutritional supplement used to treat osteoarthritis pain. The effectiveness of glucosamine has been questioned for many years and a study from a University of British ... Read More
Artificial Disc Approved By FDA as Alternative Surgical Treatment for Low Back Pain
Tuesday October 26, 2004
The Food and Drug Administration has approved an artificial spinal disc for use in treating pain associated with degenerative disc disease (DDD). The device is intended to replace a diseased ... Read More
Rheumatoid Arthritis Screening Quiz
Monday October 25, 2004
Rheumatoid arthritis is an inflammatory form of arthritis and is considered an autoimmune disease. Early diagnosis and early, aggressive treatment can help prevent joint damage and deformity. A ... Read More
POLL: When Did You Consult a Rheumatologist?
Friday October 22, 2004
A rheumatologist is a medical doctor who specializes in arthritis and rheumatic diseases. Early treatment of arthritis is important for controlling pain and joint damage. At first, when people suspect ... Read More
Electric Toothbrushes
Tuesday October 19, 2004
An electric toothbrush can make dental care much easier for people with arthritis and manual dexterity problems. Find the right electric toothbrush for you, considering the thickness of the handle ... Read More
Pfizer Announces New Clinical Trial for Celebrex
Monday October 18, 2004
Pfizer announced today it will sponsor a major clinical study to further assess its COX-2 medication Celebrex in osteoarthritis patients at high risk for cardiovascular disease. In a press ... Read More
Mycophenolate Mofetil: Lupus Study Shows CellCept Effective and Well Tolerated
Monday October 18, 2004
Mycophenolate mofetil (CellCept) is effective for managing symptoms of systemic lupus erythematosus, the most common type of lupus, for patients whose condition does not affect the kidneys. Mayo Clinic researchers ... Read More
Injectable Methotrexate: Availability Reduced
Monday October 18, 2004
American Pharmaceutical Partners Inc (APP), the major producer for the methotrexate injectable, is currently on backorder for production of methotrexate 50 and 200mg, 25mg/ml injectable vials with preservative. The ... Read More
Did FDA Turn Their Back on Concerns About Vioxx?
Friday October 15, 2004
When arthritis drug Vioxx was voluntarily withdrawn from the market on Sept. 30 by Merck, the Government Accountability Office, an investigative arm of Congress, was asked to assess the Food ... Read More
Bextra: More Information About Possible Side Effects Released By Pfizer
Friday October 15, 2004
Pfizer has released more information about Bextra. Since 2002, the Bextra product label has included information regarding the risk of a very rare but serious skin reaction. The risk exists ... Read More
Bush Health Care Plan vs. Kerry Health Care Plan
Thursday October 14, 2004
The third and last presidential debate was aimed at Senator John Kerry and President George W. Bush's base of loyal supporters with the hope it would swing some of the ... Read More
Pill Boxes
Thursday October 14, 2004
For people who take medications on a regular basis, a pill box or pill reminder is a useful item. Pill boxes are easy to take along, no matter where you ... Read More
Walkers - Rolling Walkers
Wednesday October 13, 2004
People with chronic arthritis unfortunately can lose mobility and lose independence, especially when walking becomes difficult. Walkers are mobility aids which offer additional support to compensate for lost strength, helping ... Read More
Remicade Maker Warns Doctors About Lymphoma Risk
Tuesday October 12, 2004
The maker of Remicade, a prescription drug for rheumatoid arthritis, is sending warning letters to doctors regarding a higher risk of lymphoma for patients taking the drug. Claiming this ... Read More
More Fallout From Vioxx Recall
Wednesday October 6, 2004
There has been more concern following last week's recall of arthritis drug Vioxx. Today the New England Journal of Medicine rushed an online version of two stories which will ... Read More
Stem Cell Research: Understanding the Issue
Tuesday October 5, 2004
Before you can support or oppose stem cell research, you must fully understand the terminology, the potential, and consequences. Our
2-page feature helps you understand the current status of stem cell ... Read More
POLL: Do You Support or Oppose Embryonic Stem Cell Research?
Tuesday October 5, 2004
Stem cell research is a very controversial issue which has been turned into a political issue, religious issue, and quality of life issue. Do you support or oppose embryonic ... Read More
Vioxx Recall Raises Questions
Monday October 4, 2004
Merck's voluntary withdrawal of arthritis drug Vioxx from the market last Thursday has raised questions. Reuters.com reported that some analysts and cardiologists are criticizing the FDA for not ... Read More